Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positiv...
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Emerging molecular studies have identified a subgroup of patients with unfavorable core-binding factor-positive (CBF)-AML who should be treated by intensified post-remission treatments. We analyzed 264 adults with CBF-AML from 2002 to 2011, and focused on 206 patients who achieved CR after standard ‘3+7’ induction chemotherapy. Patients who achieve...
Alternative Titles
Full title
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1664205385
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1664205385
Other Identifiers
ISSN
0268-3369,1476-5365
E-ISSN
1476-5365
DOI
10.1038/bmt.2014.180
